Biogen : BIIB

All Biogen Articles

606 Articles

Lee Jackson | May 7, 2017 at 10:15 AM EDT

Huge Hedge Fund, Biotech and Technology Trades Highlight Insider Buying: Apollo Global, Biogen, Twitter, DDR and More

With the markets once again bumping up against and trading around all-time highs, we were somewhat surprised to see as…

Chris Lange | Apr 26, 2017 at 9:40 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | Apr 12, 2017 at 9:10 AM EDT

Short Sellers Back Off Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 10:30 AM EDT

Short Interest Pulls Back in Major Biotechs

The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of…

Chris Lange | Mar 16, 2017 at 4:17 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

March 16, 2017: The S&P 500 closed lower on the day, down 0.17% and 4.01 points to 2,381.26. Separately the…

Jon C. Ogg | Mar 16, 2017 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods, Ciena and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods and…

Chris Lange | Mar 10, 2017 at 10:30 AM EST

Major Biotechs See a Retreat in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest decreased in most of…

Jon C. Ogg | Mar 9, 2017 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.

Lee Jackson | Mar 2, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

Thursday’s top analyst upgrades, downgrades and initiations include Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC and Pure Storage.

Chris Lange | Feb 28, 2017 at 10:15 AM EST

Short Sellers Hike Their Bets in Major Biotechs

The February 15 short interest data have been compared with the previous report, and short interest increased in all the…

Lee Jackson | Feb 23, 2017 at 8:15 AM EST

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is…

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Jon C. Ogg | Feb 7, 2017 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, Caterpillar, Nokia, UnitedHealth, Wal-Mart and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

1 … 16 17 18 19 20 … 41

Biogen : BIIB

All Biogen Articles

Huge Hedge Fund, Biotech and Technology Trades Highlight Insider Buying: Apollo Global, Biogen, Twitter, DDR and More

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Back Off Major Biotechs

Short Interest Pulls Back in Major Biotechs

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods, Ciena and More

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

Short Sellers Hike Their Bets in Major Biotechs

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Major Biotechs Scare Off Loads of Short Sellers

Top Analyst Upgrades and Downgrades: Best Buy, Caterpillar, Nokia, UnitedHealth, Wal-Mart and Many More

Short Sellers Back Off Major Biotechs

What to Expect From Major Health Care Stocks Reporting This Week

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

Huge Hedge Fund, Biotech and Technology Trades Highlight Insider Buying: Apollo Global, Biogen, Twitter, DDR and More

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Back Off Major Biotechs

Short Interest Pulls Back in Major Biotechs

Thursday’s Biggest Winners and Losers in the S&P 500

Top Analyst Upgrades and Downgrades: Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods, Ciena and More

Major Biotechs See a Retreat in Short Interest

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

Short Sellers Hike Their Bets in Major Biotechs

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Major Biotechs Scare Off Loads of Short Sellers

Top Analyst Upgrades and Downgrades: Best Buy, Caterpillar, Nokia, UnitedHealth, Wal-Mart and Many More

Short Sellers Back Off Major Biotechs

What to Expect From Major Health Care Stocks Reporting This Week

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%